secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2025-12-02T23:59:59+00:00
Accession:  0001193125-25-305475
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma stockholders elect directors and ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- 22,327,761 shares present (85.06% of outstanding); all proposals passed.
- Directors Dr. Jerel Banks (22,150,169 for) and Megan Boston (21,693,741 for) elected.
- Ratification of independent auditor approved: 22,252,834 for, 4,787 against.
- Advisory vote on executive compensation passed with 17,239,339 for, 4,939,686 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312525305475/0001193125-25-305475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312525305475/bntc-20251201.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-305475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer